ClearanceBrief
Recall Z-0640-04 ยท MMW System, Test, Tumor Marker, Monitoring, Bladder

Vysis

ProbeChek Vysis UroVysion Control Slides, for Fluorescence in situ Hybridization (FISH) using Vysis UroVysion Bladder Recurrence Kit; an invitro diagnostic; fixed, cultured normal human male lymphoblast cell line (negative target) and fixed culture human bladder carcinoma cell line specimens (positive), applied to glass microscope slides; catalog #30-805070, 3 slides per kit; Vysis, Inc., Downers

DateJul 20, 2004 (initiated Feb 19, 2004)
StatusTerminated
ReasonSome of the control slides did not have adequate cells deposited upon their surface.
Root causeOther
ActionVysis telephoned their customers who received the two affected lots of slides beginning on 2/18/04, informing them of the complaints of missing cells on the control slides. The accounts were requested to check their stocks for any remaining slides from these two lots and return them to Vysis for replacement.
Quantity234 kits
DistributionDOmestically to accounts in Michigan, South Carolina, Illinois, Ohio, Connecticut, Arizona, New York, Texas, California, Oklahoma, Maryland, Virginia, Utah, Florida, Louisiana, Montana, Arkansas, Massachusetts, Minnesota, Missouri and North Carolina, and internationally to Germany and Japan.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K011031VYSIS UROVYSION BLADDER CANCER RECURRENCE KIT
Vysis, Aug 3, 2001
K013785UROVYSION BLADDER CANCER RECURRENCE KIT
Vysis, Feb 8, 2002